Table 2.
Clinical and histopathological characteristics of ten non-small cell lung cancer patients.
| Factors | Subgroup | N | % |
|---|---|---|---|
| Median age at baseline | 69.9 y (45–70) | ||
|
| |||
| Sex | Male | 6 | 60 |
| Female | 4 | 40 | |
|
| |||
| Smoker | Yes | 5 | 50 |
| No | 2 | 20 | |
| Unknown | 3 | 30 | |
|
| |||
| ECOG PS | 0-1 | 10 | 100 |
| 2 | 0 | 0 | |
|
| |||
| Histopathology | Adenocarcinoma | 9 | 90 |
| Squamous cell | 1 | 10 | |
|
| |||
| Mutational status | EGFR mutation | 0 | 0 |
| ALK translocation | 1 | 10 | |
| ROS1 translocation | 1 | 10 | |
| None | 8 | 80 | |
|
| |||
| Metastasis location | Bone | 1 | 10 |
| Liver | 1 | 10 | |
| Contralateral lung | 4 | 40 | |
| Adrenal gland | 1 | 10 | |
| Brain | 3 | 30 | |
|
| |||
| Chemotherapy | CDDP-pemetrexed | 7 | 70 |
| CDDP-gemcitabine | 2 | 20 | |
| CDDP-taxotere | 1 | 10 | |